IGC Pharma, Inc.
Price Action
Technical Summary
WEAKENINGIGC Pharma, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 25), showing significant lag compared to the market leaders. Earnings contraction of 62% provides fundamental context to the price action. Investors should exercise caution due to high volatility (59% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.28 | -4.71% | BELOW |
| 50 SMA | $0.30 | -10.04% | BELOW |
| 100 SMA | $0.29 | -6.61% | BELOW |
| 150 SMA | $0.29 | -8.37% | BELOW |
| 200 SMA | $0.32 | -15.93% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is IGC in an uptrend right now?
IGC has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is IGC overbought or oversold?
IGC's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.
Is IGC outperforming the market?
IGC has a Relative Strength (RS) Rating of 25 out of 99. IGC is currently lagging the broader market.
Where is IGC in its 52-week range?
IGC is trading at $0.27, which is 54% of its 52-week high ($0.50) and 10% above its 52-week low ($0.24).
How volatile is IGC?
IGC has a Beta of 1.14 and 52-week volatility of 59%. It's more volatile than the S&P 500 - expect bigger swings.